MMP14 and geroderma osteodysplastica: The intricate interplay between inflammatory mediators, aberrant ECM accumulation, and MMP14-mediated tissue remodeling represents a fundamental axis in GO pathogenesis, highlighting these molecular pathways as compelling candidates for therapeutic targeting.